Chief Legal Officer · Nurix Therapeutics, Inc. · Nurix Therapeutics, Inc. — Employee Stock Option (right to buy)
Side
M
Value
—
Shares
3,760
Price
—
Executed
Jan 20, 2026
Disclosed
Jan 20, 2026
Disclosure timeline0 days from execution to publication · legal deadline 2 business days
Jan 20 executedJan 20, 2026 disclosed
NRIX · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Option exercise — administrative, little informational value
Relative size+13 / 25
No reported dollar value · 77.0% of prior position
Filing timing0 / 15
Disclosed 0 business days after execution (deadline: 2)
Historical behavior+4 / 15
3 prior trades recorded in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Nurix Therapeutics, Inc. — Employee Stock Option (right to buy)
Ticker
NRIX
Shares
3,760
Price per share
$0
Execution date (reported)
Jan 20, 2026
Owned after transaction
8,643 shares
Rule 10b5-1 plan
Yes, as checked by the filer
Days from execution to publication
0
What this establishes
Ring Christine filed this Form 4 reporting a option exercise of NRIX on Jan 20, 2026. It became public on Jan 20, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Legal Officer
Ring Christinecik:0001817199
Issuer
Nurix Therapeutics, Inc.cik:0001549595
Revision history · 0
No field has changed since this record was first ingested.
